Found: 16
Select item for more details and to access through your institution.
Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertension.
- Published in:
- American Journal of Health-System Pharmacy, 2007, v. 64, n. 11, p. 1187, doi. 10.2146/ajhp060380
- By:
- Publication type:
- Article
The association between adherence to levodopa/carbidopa/entacapone therapy and healthcare utilization and costs among patients with Parkinson's disease: a retrospective claims-based analysis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Valsartan versus lisinopril or metoprolol to prevent cardiovascular events in patients with hypertension
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria.
- Published in:
- PharmacoEconomics, 2020, v. 38, n. 9, p. 981, doi. 10.1007/s40273-020-00929-z
- By:
- Publication type:
- Article
Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review.
- Published in:
- Transfusion, 2007, v. 47, n. 10, p. 1919, doi. 10.1111/j.1537-2995.2007.01416.x
- By:
- Publication type:
- Article
Use of ICD-9 coding as a proxy for stage of disease in lung cancer.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2002, v. 11, n. 8, p. 709, doi. 10.1002/pds.759
- By:
- Publication type:
- Article
Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 4, p. 263, doi. 10.1002/ajh.21049
- By:
- Publication type:
- Article
Impact of rivastigmine use on the risk of nursing home placement in a US sample.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Drug Persistency of Two Cholinesterase Inhibitors: Rivastigmine versus Donepezil in Elderly Patients with Alzheimer’s Disease.
- Published in:
- Drugs & Aging, 2005, v. 22, n. 8, p. 695, doi. 10.2165/00002512-200522080-00006
- By:
- Publication type:
- Article
Risk of Antipsychotic Drug Use in Patients with Alzheimer's Disease Treated with Rivastigmine.
- Published in:
- Drugs & Aging, 2004, v. 21, n. 6, p. 395, doi. 10.2165/00002512-200421060-00004
- By:
- Publication type:
- Article
Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models.
- Published in:
- International Journal of Geriatric Psychiatry, 2011, v. 26, n. 5, p. 483, doi. 10.1002/gps.2551
- By:
- Publication type:
- Article
Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease.
- Published in:
- International Journal of Geriatric Psychiatry, 2007, v. 22, n. 5, p. 485, doi. 10.1002/gps.1806
- By:
- Publication type:
- Article
TREATMENT PERSISTENCY WITH RIVASTIGMINE AND DONEPEZIL IN A LARGE STATE MEDICAID PROGRAM.
- Published in:
- 2005
- By:
- Publication type:
- Letter